These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2976163)

  • 1. [Results of the treatment of patients with advanced breast with large doses of medroxyprogesterone acetate].
    Zulichowska J; Krawczyk J; Glińska H
    Pol Tyg Lek; 1988 May; 43(22):712-4. PubMed ID: 2976163
    [No Abstract]   [Full Text] [Related]  

  • 2. Medroxyprogesterone acetate at very high doses in postmenopausal advanced breast cancer patients.
    Pannuti F; Longhi A; Martoni A; Piana E; Baroni M
    Chemioterapia; 1987 Dec; 6(6):396-8. PubMed ID: 2963702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral plus intramuscular medroxyprogesterone acetate (high dose Farlutal) in advanced breast cancer.
    Ngelangel CA; Jimenez MV; Villalon AH; Agustin BM
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):634-7. PubMed ID: 2940689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone therapy in advanced breast cancer: high dose medroxyprogesterone acetate (MAP) vs tamoxifen (TMX). Preliminary results.
    Pannuti F; Martoni A; Fruet F; Strocchi E; Di Marco AR
    Eur J Cancer (1965); 1980; Suppl 1():93-8. PubMed ID: 6459237
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical trial of combined hormone therapy (MAP + TAM) for metastatic breast cancer.
    Pannuti F; Martoni A; Piana E; Tomasi L; Grieco A; Farris A; Saccani F; Baroni M
    Chemioterapia; 1984 Aug; 3(4):211-5. PubMed ID: 6241846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MPA at high doses in advanced breast cancer: a statistical evaluation.
    Pannuti F; Camaggi CM; Strocchi E; Martoni A
    Chemioterapia; 1986 Jun; 5(3):159-63. PubMed ID: 2941172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral route administration of medroxyprogesterone acetate (MAP) at high doses in the treatment of advanced breast cancer: clinical results.
    Guarnieri A; Tucci E; D'Aniello C; Carli A; Mariani L; De Stefano A; Nardi P
    Chemioterapia; 1984 Oct; 3(5):320-3. PubMed ID: 6241848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mammary gland carcinoma treated by large-dose medroxyprogesterone acetate of which pulmonary metastases disappeared and a selection of hormone, chemoimmunological treatment].
    Matsumoto S; Kutsuna T; Tann M; Mizuno Y; Shinohara M; Kimura T; Banno T; Yoshizaki S
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2457-9. PubMed ID: 2526619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic effects of medroxyprogesterone acetate in recurrent or advanced breast cancer].
    Yoshida M; Murai H; Miura S
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):516-23. PubMed ID: 3159345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sequential therapy with antiestrogens and progestational drugs in carcinoma of the breast in an advanced stage].
    Palmeri R; Papalia E; Lazzara S; Belnome NA; Gorgone S; Calbo E; Melita P
    Chir Ital; 1987 Apr; 39(2):185-92. PubMed ID: 2958166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical investigation of oral high-dose medroxyprogesterone acetate (MPA) in advanced breast cancer--double-blind controlled study: Japanese Group for MPA Treatment of Breast Cancer].
    Izuo M; Tominaga T; Yoshida M; Nomura Y; Abe O; Enomoto K; Kubo K; Takatani O
    Gan No Rinsho; 1985 May; 31(5):487-93. PubMed ID: 3160869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the results of treatment with medroxyprogesterone acetate (MPA) of patients with advanced breast cancer].
    Pieńkowska F; Siedlecki P; Pieńkowski T; Zborzil J; Rubach M
    Nowotwory; 1985; 35(3):243-8. PubMed ID: 2935789
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II evaluation of oral medroxyprogesterone acetate in advanced breast cancer: a Northern California Oncology Group Study.
    Tan YO; Hendrickson C; McWhirter K; Kohler M; Hannigan JF; Carlson RW
    Cancer Treat Rep; 1987 Oct; 71(10):969-70. PubMed ID: 2958131
    [No Abstract]   [Full Text] [Related]  

  • 14. High-dose oral medroxyprogesterone acetate in heavily pretreated patients with metastatic breast cancer.
    Goss PE; Ashley S; Powles TJ; Coombes RC
    Cancer Treat Rep; 1986 Jun; 70(6):777-9. PubMed ID: 2942246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metastatic breast cancer: a comparative study of the efficacy of tamoxifen and the sequential administration of tamoxifen and medroxyprogesterone acetate].
    Giralt E; Jouve M; Palangie T; Bretaudeau B; Asselain B; Magdelenat H; Merle S; Zajdela A; Pouillart P
    Bull Cancer; 1984; 71(1):22-9. PubMed ID: 6324934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral high-dose medroxyprogesterone acetate (MPA) in the treatment of advanced and recurrent breast cancer: a dose-response evaluation].
    Tominaga T; Izuo M; Nomura Y; Kubo K; Abe O; Enomoto K; Takatani O
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1994-2004. PubMed ID: 6223590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential hormone-chemotherapy (MAP at high doses and CMF) in metastatic breast cancer. Preliminary results.
    Pannuti F; Di Marco AR; Rossi AP; Rocchetta G; Rubino I; Giovannini M; Fruet F
    Panminerva Med; 1981; 23(2):93-6. PubMed ID: 6459558
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of high doses of medroxyprogesterone acetate in the palliative treatment of advanced breast cancer. Clinical experience with 44 cases].
    Amadori D; Ravaioli A; Barbanti F
    Minerva Med; 1977 Dec; 68(59):3967-80. PubMed ID: 74811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medroxyprogesterone acetate versus tamoxifen in the therapy of advanced breast cancer.
    Lorenz I; Mechl Z
    Neoplasma; 1985; 32(1):119-24. PubMed ID: 3157070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with progestins and tamoxifen in advanced breast cancer: A preliminary report.
    Trodella L; Ausilli-Cefaro GP; Turriziani A; Saccheri S; Venturo I; Minotti G
    Am J Clin Oncol; 1982 Oct; 5(5):495-9. PubMed ID: 6217741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.